SCHEMBL13464403

SCHEMBL13464403

CN(C)CCNc1ccc(O)c2c1C(=O)c1cccc(Cl)c1C2=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO1 P15559 1/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ HIF1A Q16665 2/20 0.48
▸ BRCA1 P38398 1/20 0.48
▸ CYP19A1 P11511 1/20 0.47
▸ MEN1 O00255 5/20 0.45
▸ KMT2A Q03164 5/20 0.45
▸ BLM P54132 4/20 0.45
▸ LMNA P02545 3/20 0.45
▸ MAPK1 P28482 3/20 0.45
▸ RECQL P46063 3/20 0.45
▸ EGFR P00533 3/20 0.45
▸ USP2 O75604 2/20 0.45
▸ TP53 P04637 2/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ MTOR P42345 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ NSD2 O96028 2/20 0.45
▸ HTT P42858 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15957181 0.90 SMN1; SMN2 (0.52) NQO1SMN1; SMN2HIF1ABRCA1CYP19A1
SCHEMBL3790990 0.90 TERT (0.53) NQO1SMN1; SMN2HIF1ABRCA1CYP19A1
SCHEMBL29852887 0.88 TERT (0.56) NQO1SMN1; SMN2HIF1ABRCA1CYP19A1
SCHEMBL5086164 0.88 TERT (0.56) NQO1SMN1; SMN2HIF1ABRCA1CYP19A1
SCHEMBL10623157 0.88 NQO1 (0.54) NQO1SMN1; SMN2HIF1ABRCA1CYP19A1
SCHEMBL3421479 0.86 TERT (0.53) SMN1; SMN2HIF1ABRCA1MEN1KMT2A
SCHEMBL31218592 0.86 SMN1; SMN2 (0.62) NQO1SMN1; SMN2HIF1ABRCA1CYP19A1
SCHEMBL15691061 0.85 TERT (0.48) NQO1SMN1; SMN2HIF1ABRCA1CYP19A1
SCHEMBL11277491 0.85 CYP19A1 (0.62) NQO1SMN1; SMN2HIF1ABRCA1CYP19A1
SCHEMBL3418071 0.85 CYP19A1 (0.62) NQO1SMN1; SMN2HIF1ABRCA1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8715944-B2 Fluorochromes for organelle tracing and multi-color imaging ENZO LIFE SCIENCES, INC. (US) 2014-05-06 — — US disclosed
US-20100062460-A1 Novel fluorochromes for organelle tracing and multi-color imaging ENZO LIFE SCIENCES, INC. 2010-03-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100062460-A1 Novel fluorochromes for organelle tracing and multi-color imaging MFN2, TFEB, NUMA1 NQO1 1089/4885SMN1; SMN2 2265/4885HIF1A 3695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback